Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein, a leading provider of health care solutions, will release its Q1 2022 financial results on May 3, 2022, before market opening. The live webcast of the earnings call starts at 10:00 a.m. Eastern time on the same day. Key speakers include Stanley M. Bergman and Ronald N. South, the new CFO. Investors can access the call via www.henryschein.com/IRwebcasts. Henry Schein, headquartered in Melville, N.Y., operates in 32 countries and reported sales of $12.4 billion in 2021.
Henry Schein, the leading provider of healthcare solutions, announced the retirement of Gerald A. Benjamin as Chief Administrative Officer, effective
Henry Schein, the leading provider of health care solutions, has promoted Jennifer Ferrero to Vice President, Senior Counsel and Corporate Secretary, effective July 1, 2022. Ms. Ferrero has been with the company since 2004, previously serving as Vice President, Senior Counsel, Corporate & Deputy Secretary. In her new role, she will oversee corporate governance and board activities. CEO Stanley M. Bergman commended her for her leadership and expertise, particularly in Environmental, Social & Governance (ESG) matters.
Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in the Piper Sandler Dental Investor Day on March 29, 2022, at 9:00 a.m. Eastern time. Investors can access the live webcast on the company's website, with a replay available afterward. Headquartered in Melville, N.Y., Henry Schein serves over 1 million customers globally, reporting sales of $12.4 billion in 2021. The company is a member of the S&P 500 and has a broad product portfolio and a network of over 21,600 employees.
Henry Schein has been recognized as one of the 2022 World’s Most Ethical Companies by Ethisphere for the 11th consecutive year, being the only honoree in the Healthcare Products industry. The recognition highlights the company’s commitment to ethical practices, aligning with its philosophy of ‘doing good’ to achieve business success. The Ethics Index shows that honorees outperformed a comparable index by 24.6 percentage points over five years, emphasizing the financial benefits of ethical governance.
Henry Schein (NASDAQ: HSIC) announces its role as a founding sponsor of Women in DSO®, supporting the inaugural event ‘Empower and Grow 2022’ from March 9-11, 2022, in Las Vegas. The company will sponsor keynote speaker Bonnie St. John, a renowned Paralympic medalist. This initiative reflects Henry Schein’s commitment to enhancing female leadership in the dental industry, providing mentorship, networking opportunities, and resources through their Women's Leadership Network.
Henry Schein, Inc. (NASDAQ: HSIC) showcased a diverse array of products and services at the 2022 Chicago Midwinter Dental Meeting, emphasizing advancements in dental practice performance. Key highlights included the launch of the Medit i700 intraoral scanner and Septodont BioRoot Flow root canal sealer. The company also introduced Jarvis for Private Practices, enhancing practice analytics. Visitors engaged with leaders from multiple renowned dental product companies while exploring solutions aimed at optimizing workflow efficiency. The meeting, held from February 24-26, 2022, provided a platform for networking and learning innovations in oral health.
Henry Schein, Inc. (NASDAQ: HSIC) has launched a virtual program titled “Optimism and Opportunities in Oral Health,” coinciding with the Chicago Midwinter Dental Meeting. This on-demand program features discussions with ASDA leaders and Henry Schein executives, focusing on the dental profession's evolution. CEO Stanley Bergman emphasized the importance of sharing insights for the advancement of dentistry. This initiative reflects the company's commitment to oral health as part of overall healthcare.
Zahn Dental, the dental laboratory business of Henry Schein, has committed $150,000 to Feeding America to aid communities facing food insecurity, particularly seniors. This contribution aims to enhance access to nutrition and combat malnutrition among elderly individuals, who often suffer from chronic conditions affecting their dietary needs. Zahn's supplier partners will also support this initiative. Feeding America highlights that over 38 million people in the U.S. face food insecurity, an issue worsened by the pandemic. This partnership aligns with Zahn's mission to link oral health with overall well-being.
Henry Schein reported fourth-quarter 2021 net sales of $3.3 billion, a 5.2% increase year-over-year. GAAP diluted EPS from continuing operations rose to $1.05, up from $0.99 a year earlier. Non-GAAP diluted EPS also increased to $1.07 from $1.00.
The company projects 2022 GAAP diluted EPS between $4.75 and $4.91, reflecting 7% to 10% growth from 2021. Global dental sales reached $2.0 billion for the quarter, a 9.4% rise, while medical sales declined by 3.2%. The company continues to focus on operational improvements and technology services.